Literature DB >> 7428292

The influence of indomethacin on renal haemodynamics in sickle cell anaemia.

P E de Jong, T W de Jong-Van Den Berg, G S Sewrajsingh, H Schouten, A J Donker, L W Statius van Eps.   

Abstract

1. Glomerular filtration rate and effective renal blood-flow were normal in a series of patients with sickle cell anaemia. Fractional creatinine excretion and fractional urea excretion were increased. 2. During indomethacin administration there were significant falls in glomerular filtration rate, effective renal blood-flow, creatinine clearance and urea clearance in the patients with sickle cell anaemia; fractional urea excretion also fell markedly. In control subjects none of these variables changed after indomethacin. 3. Serum concentration of urea rose markedly during indomethacin administration in sickle cell anaemia, owing to both the decrease in glomerular filtration rate and the increase in fractional urea reabsorption. 4. We conclude that prostaglandins have an important role in maintaining a normal glomerular filtration rate and effective renal blood-flow in sickle cell anaemia. The abnormal urea handling in patients with this disease remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428292     DOI: 10.1042/cs0590245

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

Review 1.  Management of pain in sickle-cell disease.

Authors:  Iheanyi Okpala; Adel Tawil
Journal:  J R Soc Med       Date:  2002-09       Impact factor: 5.344

Review 2.  End stage renal disease in sickle cell disease: future directions.

Authors:  C R Tomson
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

3.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 4.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

5.  Use of anti-inflammatory analgesics in sickle-cell disease.

Authors:  J Han; S L Saraf; J P Lash; V R Gordeuk
Journal:  J Clin Pharm Ther       Date:  2017-07-10       Impact factor: 2.512

6.  Acute kidney injury in children with sickle cell disease-compounding a chronic problem.

Authors:  Cherry Mammen; Mei Lin Bissonnette; Douglas G Matsell
Journal:  Pediatr Nephrol       Date:  2017-03-28       Impact factor: 3.714

7.  Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.

Authors:  Santosh L Saraf; Justin R Sysol; Alexandru Susma; Suman Setty; Xu Zhang; Krishnamurthy P Gudehithlu; Jose A L Arruda; Ashok K Singh; Roberto F Machado; Victor R Gordeuk
Journal:  Transl Res       Date:  2018-02-02       Impact factor: 7.012

8.  Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Authors:  Pablo Bartolucci; Anoosha Habibi; Thomas Stehlé; Gaetana Di Liberto; Marie Georgine Rakotoson; Justine Gellen-Dautremer; Sylvain Loric; Stéphane Moutereau; Dil Sahali; Orianne Wagner-Ballon; Philippe Remy; Philippe Lang; Philippe Grimbert; Etienne Audureau; Bertrand Godeau; Frédéric Galacteros; Vincent Audard
Journal:  J Am Soc Nephrol       Date:  2015-11-19       Impact factor: 10.121

9.  Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Anthony J Croatt; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-27

Review 10.  The glomerulopathy of sickle cell disease.

Authors:  Kenneth I Ataga; Vimal K Derebail; David R Archer
Journal:  Am J Hematol       Date:  2014-06-19       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.